# A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

> **NCT02241772** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xention Ltd** · enrollment: 42 (actual)

## Conditions studied

- Elevated Lp(a)

## Interventions

- **DRUG:** TA-8995
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02241772
- **Lead sponsor:** Xention Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02241772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02241772, "A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02241772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*